Product image of Glucose Baxter Holding (Glucose) supplied by GNH India

Glucose Baxter Holding

Active Ingredient:
Glucose
Origin:
EU

Glucose Baxter Holding (Glucose)

Glucose Baxter Holding is an intravenous glucose solution used as an excipient in clinical settings. The product contains glucose as the active ingredient and is supplied without a specified strength or dosage form, typical for sterile solutions administered intravenously in the European Union market.

Manufacturer / TM Owner

Baxter Holding B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose Baxter Holding serves as a source of carbohydrate and energy in various medical and laboratory applications. It is commonly employed in the following contexts:

  • Intravenous fluid therapy to maintain blood glucose levels during surgery or critical care.
  • Diluent for reconstituting powdered medications for intravenous administration.
  • Component of parenteral nutrition formulations for patients unable to eat orally.
  • Laboratory reagent for cell culture media and biochemical assays.
  • Vehicle for delivering other intravenous drugs in clinical trials.

Side Effects

Glucose Baxter Holding may be associated with certain adverse reactions, although many patients tolerate it well.

Common

  • Mild hyperglycemia detected in blood glucose monitoring.
  • Transient nausea or vomiting following infusion.
  • Local irritation at the infusion site.
  • Mild electrolyte imbalance, such as low potassium.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reaction presenting as rash, itching, or anaphylaxis.
  • Fluid overload causing pulmonary edema in susceptible patients.

Precautions & Warnings

When using Glucose Baxter Holding, healthcare professionals should consider several safety measures:

  • Assess baseline blood glucose and monitor levels during and after infusion.
  • Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload.
  • Use caution in diabetic patients; tailor dosing to individual glycemic control needs.
  • Verify compatibility with other intravenous solutions before mixing.
  • Ensure sterile technique to prevent contamination and infection.
  • Document any adverse reactions promptly in the patient record.

Avoid Interactions

Glucose Baxter Holding can interact with other agents administered intravenously. Awareness of these interactions helps maintain patient safety.

Avoid

  • Co-administration with high-dose insulin without appropriate monitoring, which may cause severe hypoglycemia.
  • Simultaneous infusion of potassium chloride solutions, which can increase the risk of hyperkalemia.

Use with caution

  • Concurrent use of diuretics that may alter fluid and electrolyte balance.
  • Administration alongside medications that affect glucose metabolism, such as glucocorticoids.
  • Mixing with certain antibiotics that may precipitate if pH is not compatible.

Frequently Asked Questions

Glucose Baxter Holding is used as an intravenous source of glucose to provide energy, maintain blood sugar levels, and serve as a diluent for reconstituting other IV medications.

Yes, but blood glucose should be closely monitored and infusion rates adjusted to avoid hyperglycemia, as diabetic patients have altered glucose metabolism.

Compatibility depends on the specific antibiotic and solution pH; it is recommended to check manufacturer guidelines or perform a compatibility test before mixing.

Regular monitoring of blood glucose, electrolytes, and fluid balance is advised, especially in patients with renal, cardiac, or metabolic disorders.

The product should be stored according to the manufacturer’s instructions, typically at controlled room temperature, protected from light, and used before the expiration date.

Common reactions include mild hyperglycemia, nausea, vomiting, and local irritation at the infusion site.

Serious side effects such as severe hyperglycemia, allergic reactions, or fluid overload can occur in patients with underlying cardiac, renal, or metabolic conditions if not monitored.

It may be used in pediatric care under strict medical supervision, with dosing and monitoring adjusted for the child's size and metabolic needs.

Glucose Baxter Holding is classified as an excipient, providing a carrier or diluent function rather than a therapeutic effect.

Stop the infusion immediately, assess the patient, and provide appropriate medical treatment such as antihistamines or epinephrine, following standard anaphylaxis protocols.

No specific ATC code is assigned to Glucose Baxter Holding because it is categorized as an excipient rather than a therapeutic drug.

During surgery, glucose levels are closely monitored, and the infusion rate may be adjusted to match the patient’s metabolic demands and fluid status.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.